EMBLA Stock Price, News & Analysis

Embla Medical hf (EMBLA) is a medical company listed on Nasdaq Copenhagen. According to company announcements, Embla Medical was founded in Reykjavik in 1971 with the mission to improve people's mobility. The company describes itself as a global provider of mobility solutions, operating through several brands that focus on prosthetics, neuro orthotics, bracing and supports, and patient care delivered through a network of orthotic and prosthetic (O&P) facilities.

Embla Medical states that it is home to brands that are recognized for their impact on health and well-being. These include Össur, which the company describes as a global provider of prosthetics and bracing and supports solutions; FIOR & GENTZ, described as a developer of neuro orthotics; and College Park Industries, which the company associates with custom-built prosthetic solutions. Through these brands and its O&P facilities, Embla Medical focuses on products and services that support people with mobility challenges.

The company reports that it operates globally and has more than 4,000 employees. Embla Medical highlights a commitment to sustainable business practices, noting that it is a signatory to the UN Global Compact and UN Women's Empowerment Principles and that it contributes to the UN Sustainable Development Goals. The company also states that its climate targets have been verified by the Science Based Targets initiative.

Business focus and segments

Based on its public communications, Embla Medical’s activities are organized around several areas:

• Prosthetics & Neuro Orthotics (P&NO) – The company reports this segment as a key driver of growth in multiple quarterly updates.
• Bracing & Supports – Embla Medical describes this as a separate segment focused on bracing and supports solutions.
• Patient Care – The company refers to a Patient Care segment built around a global network of O&P facilities and notes efforts to unify these facilities under the ForMotion brand in certain countries.

Embla Medical has also communicated that it is pursuing a strategy referred to as “Growth’27”, which in its own words is linked to expanding its reach and product offering, including acquisitions and brand unification within patient care. The company has highlighted the acquisition of FIOR & GENTZ and the rebranding of patient care facilities in Iceland, Sweden, and Finland to the ForMotion name as part of this effort.

Corporate development and acquisitions

Embla Medical has reported several corporate developments in its news releases. The company states that it signed an agreement to acquire, and subsequently closed, a majority share investment (51%) in Streifeneder ortho.production GmbH, described as an international developer and supplier of orthopaedic mobility solutions with offerings in prosthetic and orthotic components, orthopaedic materials, and equipment for the O&P industry. Embla Medical has communicated that this investment is intended to position it as a full-range provider to a larger part of the global O&P market and to strengthen its presence in Germany and other markets.

In connection with this investment, Embla Medical has reported issuing new shares under an authorization in its Articles of Association, with the sellers of Streifeneder ortho.production subscribing for all of the new shares and agreeing to a lock-up period. The company has also referenced a loan agreement with the Nordic Investment Bank as part of its financing activities.

Geographic footprint and operations

Embla Medical’s announcements reference operations and corporate activity in Reykjavik, Iceland, and Copenhagen, Denmark. The company states that it operates globally, with sales and performance discussed by regions such as EMEA, Americas, and APAC in its interim reports. It also notes a global network of O&P facilities and mentions rebranding patient care facilities in Iceland, Sweden, and Finland to the ForMotion brand.

Sustainability and recognition

Embla Medical emphasizes sustainability in its public information. It states that it is committed to sustainable business practices, is a signatory to the UN Global Compact and UN Women’s Empowerment Principles, and contributes to the UN Sustainable Development Goals. The company has reported that its climate targets have been verified by the Science Based Targets initiative. In one communication, Embla Medical (Össur) is described as having been ranked among the "World's Best Companies in Sustainable Growth" by TIME Magazine and Statista, with that ranking based on environmental disclosure and financial metrics.

Stock information and listing history

Embla Medical’s shares trade on Nasdaq Copenhagen under the ticker EMBLA. The company has also stated that it was formerly listed as Össur (OSSR) on Nasdaq Copenhagen until 8 April 2024. This indicates a change in listing name and ticker, with Embla Medical now representing the listed entity under the EMBLA symbol.

Financial reporting and segments

In its interim and annual reports, Embla Medical discusses performance across its segments of Prosthetics & Neuro Orthotics, Bracing & Supports, and Patient Care. The company comments on factors such as organic sales growth, regional performance in EMEA, Americas, and APAC, and the impact of manufacturing efficiency, product mix, and cost control on margins. It also refers to share buyback programs and leverage targets framed through a net interest-bearing debt to EBITDA ratio.

Embla Medical’s communications also reference external factors affecting its business, such as US Medicare coverage decisions for bionic prosthetic solutions for certain amputee patient groups and the potential impact of US trade tariffs on its financial results. The company notes that it assumes some absorption of tariffs in its guidance but considers it speculative to quantify the exact impact.

Company identity and mission

Across its news releases, Embla Medical consistently describes its mission as improving people’s mobility and helping people live what it calls a "Life Without Limitations." The company positions its portfolio of prosthetics, neuro orthotics, bracing and supports, and patient care services as central to this mission, and ties its sustainability commitments and participation in global initiatives to its broader role in health and well-being.

FAQs about Embla Medical (EMBLA)

• What does Embla Medical do?
  Embla Medical describes itself as a global provider of mobility solutions. According to its public information, it focuses on prosthetics, neuro orthotics, bracing and supports, and patient care delivered through a network of orthotic and prosthetic facilities.
• When was Embla Medical founded?
  The company states that it was founded in Reykjavik in 1971 with the mission to improve people's mobility.
• On which exchange is Embla Medical listed and under what ticker?
  Embla Medical reports that its shares trade on Nasdaq Copenhagen under the ticker symbol EMBLA.
• What brands are part of Embla Medical?
  Embla Medical states that it is home to several brands, including Össur, FIOR & GENTZ, and College Park Industries, which it associates with prosthetics, bracing and supports, neuro orthotics, and custom-built prosthetic solutions.
• What are Embla Medical’s main business segments?
  In its financial reports, Embla Medical refers to three main segments: Prosthetics & Neuro Orthotics, Bracing & Supports, and Patient Care.
• Where does Embla Medical operate?
  The company states that it operates globally, with performance discussed across EMEA, Americas, and APAC regions, and that it runs a global network of orthotic and prosthetic facilities.
• What is Embla Medical’s approach to sustainability?
  Embla Medical reports that it is committed to sustainable business practices, is a signatory to the UN Global Compact and UN Women’s Empowerment Principles, contributes to the UN Sustainable Development Goals, and has climate targets verified by the Science Based Targets initiative.
• Has Embla Medical undergone a name or ticker change?
  The company states that it was formerly listed as Össur (OSSR) on Nasdaq Copenhagen until 8 April 2024 and is now listed as Embla Medical under the EMBLA ticker.
• What recent corporate investments has Embla Medical announced?
  Embla Medical has announced a majority share investment in Streifeneder ortho.production GmbH, described as an international developer and supplier of orthopaedic mobility solutions, and has reported issuing new shares in connection with this transaction.
• How many employees does Embla Medical have?
  In its company description, Embla Medical states that it operates globally and has more than 4,000 employees.